Clinical trials: Initial-onset Gastric Cancer
Gastric Cancer, Metaplasia
Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor
This is a study of the safety and effectiveness of Trametinib treatment in patients who have received successful endoscopic submucosal resection of a Stage I gastric cancer.
- Conditions
- Gastric Cancer, Metaplasia, Stage I Gastric Cancer, Initial-onset Gastric Cancer
- Trial name
- NCT04454476
- Testing
- Trametinib treatment, Endoscopy
- Where
- 3 sites in Japan
- Volunteers
- 15 people
- Sponsor
- Vanderbilt-Ingram Cancer Center